abstract |
Disclosed are methods of treating hyperproliferative disorders, method of treating inflammatory disorders, and methods of inhibiting MEK activity in a mammal, comprising administering an effective amount of one or more compounds of the Formula V n n n n n n n n n n or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 7 , R 8 , R 9 and W are as defined in the specification. |